← Insider buys
ALRN

Aileron Therapeutics, Inc.

Novartis Bioventures Ltd sold $236K of Aileron Therapeutics, Inc.

10% owner

Sold$236,258
$1.86Price
127,150Shares
−6%Stake

What ALRN did after the filing

Prices for ALRN after this filing aren't in yet.

Traded Fri, Mar 29. Filed Tue, Apr 2. Not investment advice.